OC-0504 Randomized phase 2 trial of adaptive dose painting vs. standard IMRT for head and neck cancer. (April 2019) - Duprez, F.; Daisne, J.; Berwouts, D.; De Gersem, W.; Goethals, I.; Olteanu, L.; Vercauteren, T.; De Neve, W.